Search Results - Fraenkel, P.G.

  • Showing 1 - 3 results of 3
Refine Results
  1. 1
    190P Combination of IPH5201, a blocking antibody targeting the CD39 immunosuppressive pathway, with durvalumab and chemotherapies: Preclinical rationale

    190P Combination of IPH5201, a blocking antibody targeting the CD39 immunosuppressive pathway, with durvalumab and chemotherapies: Preclinical rationale by Paturel, C.L., Anceriz, N., Eyles, J., Lapointe, J-M., Denis, C., Breso, V., Courtois, R., Augier, S., Brown, L., Luheshi, N., Watkins, A., Cooper, Z.A., Tu, E., Vivier, E., Fraenkel, P.G.

    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    188P IPH5201 as monotherapy or in combination with durvalumab (D) in advanced solid tumours

    188P IPH5201 as monotherapy or in combination with durvalumab (D) in advanced solid tumours by Imbimbo, M., Hollebecque, A., Italiano, A., McKean, M., Macarulla, T., Castanon Alvarez, E., Carneiro, B.A., Mager, R., Barnhart, V., Murtomaki, E., He, Y., Cooper, Z.A., Tu, E., Linke, A., Fan, C., Zhou, D., Boyer Chammard, A., Paturel, C.L., Fraenkel, P.G., Powderly, J.

    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    Excitation energy transfer from phycocyanin to chlorophyll in an apcA-defective mutant of Synechocystis sp. PCC 6803

    Excitation energy transfer from phycocyanin to chlorophyll in an apcA-defective mutant of Synechocystis sp. PCC 6803 by Su, X. (McLean Hospital and Harvard Medical School, Belmont, MA), Fraenkel, P.G, Bogorad, L

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:

Search Tools: